ParcelBio

Granza Bio

This deep-tech company develops attack particle medicines to treat patients with cancer, autoimmune diseases and infections.

GenEdit

This deep-tech firm develops polymer nanoparticle delivery systems for genetic medicines to treat autoimmune diseases for the pharmaceutical and biotechnology industries.

Helix Nanotechnologies

This deep-tech company develops an mRNA platform to create vaccines and therapies for biotechnology organisations and patients with complex immune requirements.

EditForce

This deep-tech firm develops RNA editing tools and therapies for pharmaceutical, industrial, and agricultural organisations to treat diseases and manipulate genes.

SymphoRNA

This deep-tech company develops multi-RNA combination medicines to treat complex diseases such as fibrosis and heart failure for the pharmaceutical and healthcare sectors.

Catena Biosciences

This deep-tech company develops protein conjugation technology and multi-payload conjugates to create targeted therapeutics for patients with oncology and autoimmune diseases.

Kodikaz Therapeutic Solutions

This deep-tech company develops a non-viral delivery platform for cell-specific gene therapies to treat cancer patients.

Phost'in Therapeutics

This deep-tech company develops small molecule glycocalyx modifiers to treat patients with aggressive solid tumours by restoring immune responses against cancer cells.